Author name: Hannah

Maintaining the Cold Chain: Dealing with vaccine storage incidents

Leave a Comment / Blog /

Maintaining the Cold Chain: Dealing with vaccine storage incidents What Healthcare Professionals Need to Know Vaccines are highly sensitive biological products. Their potency and safety depend on strict adherence to storage conditions, especially temperature control throughout the cold chain. Correct vaccine storage and handling has been an important factor in preventing and eradicating many common […]

Maintaining the Cold Chain: Dealing with vaccine storage incidents Read More »

The Introduction of a UK Varicella (Chickenpox) Vaccination Programme

Leave a Comment / Blog /

Did you know that chickenpox (varicella) is now a notifiable disease in England?  This means that medical professionals must report suspected or confirmed cases to the UK Health Security Agency (UKHSA) from 6th April, 2025. This change is part of a broader update to health protection notification regulations. Purpose of the Change: The UKHSA 2025

The Introduction of a UK Varicella (Chickenpox) Vaccination Programme Read More »

Neonatal Hepatitis B Pathway

Leave a Comment / Blog /

This blog provides practitioners with information on the Hepatitis B selective neonatal immunisation pathway, DBS testing at 12 months and useful resources. The introduction of the hexavalent vaccine, as part of the universal childhood immunisation programme in 2017, provided an opportunity for collaborative working by the infectious diseases in pregnancy screening programme and national immunisation

Neonatal Hepatitis B Pathway Read More »

Expanding Vaccine Roles for Health Care Support Workers

Leave a Comment / Blog /

Training Requirements and Employer Responsibilities Healthcare Support Workers (HCSW’s) are integral to the success of immunisation programmes, especially in meeting the growing demand for vaccines. However, their expanded responsibilities must align with proper training, competency, and governance. This blog focuses on the essential training requirements for HCSWs and the employer’s role in ensuring patient safety

Expanding Vaccine Roles for Health Care Support Workers Read More »

RSV Vaccine and the rare Guillain-Barré Syndrome (GBS) side effect: Understanding Prevalence and Risks

Leave a Comment / Blog /

The Respiratory Syncytial Virus (RSV) is a major cause of severe respiratory infections, especially in infants, older adults, and immunocompromised individuals. To learn more about RSV and the importance of the vaccine, view the video below. With the recent introduction of the RSV vaccine into immunisation programmes, concerns have recently emerged regarding rare side effects,

RSV Vaccine and the rare Guillain-Barré Syndrome (GBS) side effect: Understanding Prevalence and Risks Read More »

Scroll to Top